This article is more than 5 years old. Information may no longer be current.
Lurie Comprehensive Cancer Center names associate director
Click Here to Manage Email Alerts
Massimo Cristofanilli, MD, has been appointed associate director for precision medicine and translational research at Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Cristofanilli will serve as director of Northwestern OncoSET, which personalizes cancer care for patients by sequencing the individual genetic profile of their tumors and evaluating the results to provide the treatments or clinical trials that will offer the greatest benefit. He also will serve as professor of medicine in the division of hematology-oncology at Northwestern University Feinberg School of Medicine.
Massimo Cristofanilli
“We have the unprecedented opportunity to design a patient-centered, biology-driven model of cancer care combining sophisticated tissue and blood-based molecular diagnostic technologies and innovative treatments,” Cristofanilli said in a press release. “We plan to continue the establishment of strategic partnerships and to involve our patients in an educational and informative journey to advance their understanding of their disease and treatments.”
Cristofanilli, an expert in the translational research and treatment of patients with inflammatory breast cancer, joins Northwestern from Thomas Jefferson University and Hospitals, where he served as director of Jefferson Breast Care Center and deputy director of translational research at Kimmel Cancer Center.
He previously served as chair of the department of medical oncology at Fox Chase Cancer Center, and executive director of the Morgan Welch inflammatory breast cancer program and clinic at The University of Texas MD Anderson Cancer Center.